DESIGN OF PHASE-I AND PHASE-II CLINICAL-TRIALS IN CANCER - A STATISTICIANS VIEW

被引:36
作者
GELLER, NL
机构
关键词
D O I
10.3109/07357908409048522
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:483 / 491
页数:9
相关论文
共 27 条
[1]  
DEMETS DL, 1980, BIOMETRIKA, V67, P651
[2]  
DOUGLASS HO, 1976, CANCER TREAT REP, V60, P769
[3]   ONE-SAMPLE MULTIPLE TESTING PROCEDURE FOR PHASE-II CLINICAL-TRIALS [J].
FLEMING, TR .
BIOMETRICS, 1982, 38 (01) :143-151
[4]  
FORSYTHE GE, 1977, COMPUTER METHODS MAT, P178
[5]  
FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219
[6]   DETERMINATION OF NUMBER OF PATIENTS REQUIRED IN A PRELIMINARY AND A FOLLOW-UP TRIAL OF A NEW CHEMOTHERAPEUTIC AGENT [J].
GEHAN, EA .
JOURNAL OF CHRONIC DISEASES, 1961, 13 (04) :346-&
[7]  
GOLDSMITH MA, 1975, CANCER RES, V35, P1354
[8]  
JENNISON C, 1983, TECHNOMETRICS, V25, P49
[9]  
MARSONI S, 1984, PREDICTION TOXICITY
[10]  
METZLER CM, 1974, BIOMETRICS, V30, P562